Loovi: Difference between revisions
Added business details: founded 2023, funding €1M Seed (Feb 2026) |
Added cross-references: AIDAVA Competitive Analysis, AIDAVA Related Companies, Nordic Preventive Health |
||
| Line 61: | Line 61: | ||
== See Also == | == See Also == | ||
* [[AIDAVA Competitive Analysis]] | |||
* [[AIDAVA Related Companies]] | |||
* [[Nordic Preventive Health]] | |||
* [[Sweden]] | * [[Sweden]] | ||
* [[Preventive Health]] | * [[Preventive Health]] | ||
Latest revision as of 17:57, 14 April 2026
What They Do[edit]
Preventive health and longevity platform offering clinical-grade biomarker testing, doctor consultations, and personalised health plans. Tests 120+ biomarkers annually via drop-in blood draws at 80+ clinic locations across Sweden. Results within 3 days, followed by unrushed 1-on-1 doctor consultations and ongoing chat support with a dedicated health team.
Founders[edit]
- Dr. Kevin Najafi — Co-Founder & COO. Physician with ER background. Focused on preventive medicine after seeing the end-stage effects of lifestyle diseases in emergency care.
- Joel Grajcer — Co-Founder & CEO. Started optimizing personal health through bloodwork and realized data alone isn't clarity — built Loovi to translate biomarker data into actionable long-term plans.
Product[edit]
- Membership: 295 SEK/month (standard: 590 SEK/month). Onboarding fee: 1,995 SEK.
- Testing: 60+ biomarkers per blood draw at 80+ drop-in clinic locations
- Consultation: Unrushed 1-on-1 with longevity doctors
- Ongoing: Unlimited chat with health team, retesting every 6 months, personalised supplement/fitness/nutrition plan
- Corporate: Approved for Swedish Friskvårdsbidrag (wellness benefit)
- Philosophy: "Health Power Laws" — finding the 20% of effort that delivers 80% of results. Focus on early detection, cardiovascular fitness, muscle strength, metabolic health.
Revenue[edit]
Org nr: 559459-5893 Source: allabolag.se
- 2024: 273K SEK (~€24K) — first full fiscal year
- Loss 2024: -790K SEK
- Employees: 5-9
- Assets: 1,428K SEK
- Equity: 1,235K SEK
- Cash liquidity: 739.9% (very strong)
- Solvency: 86.5% (very good)
Funding[edit]
Valuation: Not publicly disclosed. €1M Seed round (Feb 2026) per EU-Startups. Investors: Not disclosed. Source: Stockholm-based Loovi secures €1 million to scale preventive health and longevity platform — EU-Startups (Feb 2026)
Traction[edit]
- 80+ clinic locations for drop-in testing across Sweden
- Website live at loovi.health with waitlist
- Active social media (Instagram, Facebook, LinkedIn)
- Approved for Friskvårdsbidrag (Swedish employer wellness benefit) — key B2B2C channel
- Early stage: only 273K SEK revenue in 2024, but 5-9 employees suggests building for scale
Competitive Position[edit]
Targets the gap between ultra-expensive longevity clinics (100K+ SEK/year) and generic "eat better" advice. Subscription model (295-590 SEK/month) makes proactive health accessible. Competes with:
- Neko Health — AI body scanning (different approach, less biomarker depth)
- Nightingale Health — blood biomarker platform (B2B focus vs Loovi B2C)
- Traditional health checks (Previa, etc.)
Business Details[edit]
- Founded: 2023
- Total Funding: €1M Seed (Feb 2026)
- Valuation: Not disclosed
- Revenue: 273K SEK (2024)
- Employees: 5-9
- Key Milestones: 80+ clinic locations. 295 SEK/month subscription. Friskvårdsbidrag approved.